Mercy Hospital

Miami, Florida 33173

1 studies enrolling now · 17 studies all time

What they study most

AFib, Abdominal (ABD) Infection, Atrial Fibrillation, Breast Cancer, Catheter Occlusion, Cervical Cancer, Endometrial Clear Cell Adenocarcinoma, Endometrial Neoplasms, Endometrial Serous Adenocarcinoma, Lung Cancer, Lymphoma, Non-Hodgkin, Mixed Mesodermal (Mullerian) Tumor

Studies at this site

• A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer — Recruiting now
• Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma — Stopped early
• Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation — Running, not enrolling
• INSPIRE Trial for Skin and Soft Tissue Infections — Completed
• INSPIRE Trial for Abdominal Infections — Completed
• Mupirocin-Iodophor ICU Decolonization Swap Out Trial — Completed
• Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer — Status unconfirmed
• Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer — Completed
• Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer — Status unconfirmed
• Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer — Status unconfirmed
• Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer — Completed
• A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer — Stopped early
• A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early
• Stroke Feasibility Study — Completed
• Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer — Completed
• Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer — Completed
• Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters — Completed